The Case for Intravenous Arginine Stimulation in Lieu of Mixed-Meal Tolerance Tests as OutCome Measure for Intervention Studies in Recent-Onset Type 1 Diabetes

Diabetes Care

Volumn 27, Issue 5, 2004, Pages 1202-1204

  Greenbaum, Carla ^a   Seidel, Kristy ^b   Pihoker, Catherine ^c  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; C PEPTIDE; GLUCAGON; GLUCOSE;

ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; INTRAVENOUS ARGININE STIMULATION; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; MIXED MEAL TOLERANCE TEST; OUTCOMES RESEARCH; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PANCREAS SECRETION; TIME SERIES ANALYSIS; VALIDATION PROCESS;

ARGININE; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; GLUCOSE TOLERANCE TEST; HUMANS; INJECTIONS, INTRAVENOUS; POSTPRANDIAL PERIOD; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 2342634653     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.5.1202     Document Type: Article

References (15)

1. Faber OK, Binder C: C-peptide response to glucagon: a test for the residual beta-cell function in diabetes mellitus. Diabetes 26:605-610, 1977
2. Greenbaum CJ: Type 1 diabetes intervention trials: what have we learned? A critical review of selected intervention trials. Clin Immunol 104:97-104, 2002
3. Bardet S, Rohmer V, Daugendre D, Marre M, Semana G, Limal JM, Allanic H, Charbonnel B, Sai P: Acute insulin response to intravenous glucose, glucagon and arginine in some subjects at risk for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 34:648-654, 1991
4. Chaillous L, Rohmer V, Maugendre D, Lecomte P, Marechaud R, Marre M, Guilhem I, Charbonnel B, Sai P: Differential beta-cell response to glucose, glucagon, and arginine during progression to type I (insulin-dependent) diabetes mellitus. Metabolism 45:306-314, 1996
5. Heinze E, Beischer W, Keller L, Winkler G, Teller WM, Pfeiffer EF: C-peptide secretion during the remission phase of juvenile diabetes. Diabetes 27:670-676, 1978
6. Savage PJ, Bennion LJ, Flock EV, Bennett PH: Beta cell dysfunction in maturity-onset diabetes: reversible loss of glucose-induced insulin secretion with retention of response to arginine. Adv Exp Med Biol 119:219-225, 1979
7. Arnold-Larsen S, Madsbad S, Kuhl C: Reproducibility of the glucagon test. Diabet Med 4:299-303, 1987
8. Ryan EA, Lakey JR, Paty BW, Imes S, Korbutt GS, Kneteman NM, Bigam D, Rajotte RV, Shapiro AM: Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 51:2148-2157, 2002
9. McCulloch DK, Koerker DJ, Kahn SE, Bonner-Weir S, Palmer JP: Correlations of in vivo beta-cell function tests with beta-cell mass and pancreatic insulin content in streptozocin-administered baboons. Diabetes 40:673-679, 1991
10. Dupre J, Jenner MR, Mahon JL, Purdon C, Rodger NW, Stiller CR: Endocrine-metabolic function in remission-phase IDDM during administration of cyclosporine. Diabetes 40:598-604, 1991
11. Ganda OP, Srikanta S, Brink SJ, Morris MA, Gleason RE, Soeldner JS, Eisenbarth GS: Differential sensitivity to beta-cell secretagogues in "early," type I diabetes mellitus. Diabetes 33:516-521, 1984
12. Giugliano D, Luyckx AS, Lefebvre PJ: Plasma C-peptide response to arginine in insulin-dependent diabetic subjects. J Endocrinol Invest 3:19-23, 1980
13. Menchini M, Meschi F, Lambiase R, Puzzovio M, Del Guercio MJ, Chiumello G: C-peptide response to arginine stimulation in diabetic children. J Pediatr 96:362-366, 1980
14. Reynolds C, Molnar GD, Horwitz DL, Rubenstein AH, Taylor WF, Jiang NS: Abnormalities of endogenous glucagon and insulin in unstable diabetes. Diabetes 26:36-45, 1977
15. Vetter U, Heinze E, Thon A, Beischer W, Teller W: The effect of glucose, tolbutamide, and arginine on C-peptide release during remission in type I diabetes mellitus. Eur J Pediatr 140:305-310, 1983